Internal Medicine

3151 questions

Question 301Question →

An 18-year-old female university student is evaluated in the emergency department after her roommate found her to be acutely disoriented. Over the last 12 hours, the patient has experienced continuous nausea, episodes of vomiting, and a persistent buzzing sensation in her ears. The roommate suspects she ingested a large quantity of an over-the-counter medication following a personal dispute. Her temperature is 37.8∘C37.8^\circ C (100∘F100^\circ F), blood pressure is 114/72114/72 mm Hg, pulse is 118118/min, and respirations are 2626/min. Physical examination shows a diaphoretic, agitated young woman with deep, rapid breathing.

Laboratory results are as follows:

Laboratory TestResult
Serum sodium140140 mEq/L
Serum potassium3.83.8 mEq/L
Serum chloride104104 mEq/L
Serum bicarbonate1212 mEq/L
Blood urea nitrogen1818 mg/dL
Serum creatinine1.01.0 mg/dL
Arterial pH7.427.42
Arterial PaO2PaO_29898 mm Hg
Arterial PaCO2PaCO_21919 mm Hg

Which of the following best describes this patient's underlying acid-base disturbance?

Show answer & explanation

Answer: Mixed high anion gap metabolic acidosis and primary respiratory alkalosis

Answer

Mixed high anion gap metabolic acidosis and primary respiratory alkalosis
The correct answer identifies a mixed high anion gap metabolic acidosis and a primary respiratory alkalosis. This patient's clinical presentation (tinnitus, tachypnea, nausea, vomiting, agitation) is highly suspicious for salicylate toxicity (aspirin overdose). The acid-base workup reveals a severely low bicarbonate (1212 mEq/L) with an elevated anion gap of 2424 mEq/L, confirming a high anion gap metabolic acidosis. Utilizing Winter's formula (Expected PaCO2=(1.5×12)+8=26±2PaCO_2 = (1.5 \times 12) + 8 = 26 \pm 2), the expected PaCO2PaCO_2 for respiratory compensation is 24−2824-28 mm Hg. The actual PaCO2PaCO_2 is 1919 mm Hg, which is lower than expected, confirming an independent, concurrent primary respiratory alkalosis.

Step-by-Step Solution

1
Evaluate the patient's arterial blood gas to identify the predominant pH direction and primary disturbances.
The pH is 7.427.42, which is normal but slightly alkalemic. The PaCO2PaCO_2 is severely low (1919 mm Hg), indicating respiratory alkalosis, and the HCO3−HCO_3^- is significantly low (1212 mEq/L), indicating metabolic acidosis.
Understanding the individual components helps recognize that two opposing primary processes are occurring simultaneously, which is characteristic of salicylate toxicity.
2
Calculate the serum anion gap to classify the metabolic acidosis.
Anion Gap =Na+−(Cl−+HCO3−)=140−(104+12)=24= Na^+ - (Cl^- + HCO_3^-) = 140 - (104 + 12) = 24 mEq/L. This reveals a high anion gap metabolic acidosis (HAGMA).
A high anion gap confirms the presence of unmeasured anions, which in this case are organic acids (lactic acid and ketoacids) secondary to salicylate-induced uncoupling of oxidative phosphorylation.
3
Apply Winter's formula to calculate the expected respiratory compensation for the degree of metabolic acidosis.
Expected PaCO2=(1.5×HCO3−)+8±2PaCO_2 = (1.5 \times HCO_3^-) + 8 \pm 2. Calculation: (1.5×12)+8=26±2(1.5 \times 12) + 8 = 26 \pm 2 mm Hg. The expected range is 24−2824-28 mm Hg.
Winter's formula determines if the patient's respiratory drive is appropriately compensating for the metabolic acidosis.
4
Compare the actual PaCO2PaCO_2 to the expected PaCO2PaCO_2 range.
The actual PaCO2PaCO_2 (1919 mm Hg) is significantly lower than the expected compensatory range (24−2824-28 mm Hg).
A PaCO2PaCO_2 lower than expected indicates excessive hyperventilation, diagnosing an independent, concurrent primary respiratory alkalosis due to direct salicylate stimulation of the medullary respiratory center.

Key Concept

Patients with acute salicylate toxicity classically present with a mixed acid-base disorder: a primary respiratory alkalosis (due to direct medullary respiratory center stimulation) and a concurrent high anion gap metabolic acidosis (due to uncoupling of oxidative phosphorylation and accumulation of organic acids).
Question 302Question →

Paramedics deliver a 68-year-old nursing home resident to the acute care bay after staff found him profoundly lethargic amid multiple episodes of bilious emesis over the preceding 48 hours. Medical history is significant for heart failure with preserved ejection fraction, severe osteoarthritis, and recently diagnosed type 2 diabetes mellitus. On initial assessment, he is obtunded but protects his airway.

Vitals:
ParameterValue
Temperature36.8°C (98.2°F)
Heart rate118/min
Blood pressure88/54 mm Hg
Respiratory rate10/min
SpO293% (room air)
Laboratory data:
TestResult
Sodium142 mEq/L
Potassium3.1 mEq/L
Chloride90 mEq/L
Bicarbonate16 mEq/L
Blood urea nitrogen58 mg/dL
Creatinine2.7 mg/dL
Glucose512 mg/dL
Arterial blood gas (room air):
ParameterValue
pH7.23
PaO274 mm Hg
PaCO240 mm Hg

Assuming a normal reference anion gap of 12 mEq/L and a normal reference serum bicarbonate of 24 mEq/L, what is this patient's delta ratio (ΔAG/ΔHCO3−\Delta AG / \Delta HCO_3^-)?

Show answer & explanation

Answer: 3

Answer

The patient's calculated delta ratio is 3.0.
This patient presents with a severe triple acid-base disorder: high anion gap metabolic acidosis (likely diabetic ketoacidosis or lactic acidosis from hypoperfusion), metabolic alkalosis (from severe vomiting), and respiratory acidosis (from obtundation causing hypoventilation). The delta ratio compares the rise in the anion gap (ΔAG\Delta AG) to the fall in bicarbonate (ΔHCO3−\Delta HCO_3^-). For every 1 mEq/L increase in unmeasured acids, the bicarbonate should theoretically fall by 1 mEq/L, yielding a ratio of 1.0 (or up to 2.0 in lactic acidosis due to varying intracellular buffering efficiency). A ratio >2.0> 2.0 indicates that the bicarbonate has not fallen as much as expected given the massive acid load. In this patient, the massive acid load (ΔAG=24\Delta AG = 24) only dropped the bicarbonate by 8 mEq/L. This proves the existence of a concurrent metabolic alkalosis (from the loss of gastric HClHCl) generating additional bicarbonate that masks the severity of the acidosis. Additionally, Winter's formula predicts a PaCO2 of 1.5(16)+8=32±21.5(16) + 8 = 32 \pm 2 mm Hg; the measured PaCO2 of 40 mm Hg confirms a concurrent respiratory acidosis.

Step-by-Step Solution

1
Calculate the serum anion gap using the formula AG=Na+−(Cl−+HCO3−)AG = Na^+ - (Cl^- + HCO_3^-).
142−(90+16)=142−106=36142 - (90 + 16) = 142 - 106 = 36 mEq/L.
The first step in evaluating any metabolic acidosis is determining if unmeasured anions are present.
2
Calculate the change in anion gap (ΔAG\Delta AG).
36−12=2436 - 12 = 24 mEq/L.
This determines the exact magnitude of excess unmeasured acid that has accumulated in the blood above the normal baseline.
3
Calculate the change in bicarbonate (ΔHCO3−\Delta HCO_3^-).
24−16=824 - 16 = 8 mEq/L.
This determines how much the serum bicarbonate has dropped from its baseline normal value due to buffering the acid load.
4
Calculate the delta ratio by dividing ΔAG\Delta AG by ΔHCO3−\Delta HCO_3^-.
24/8=3.024 / 8 = 3.0.
Evaluating the ratio between the rise in unmeasured acids and the fall in bicarbonate helps identify concurrent secondary metabolic acid-base disorders.

Key Concept

In patients with a high anion gap metabolic acidosis, the delta ratio (ΔAG/ΔHCO3−\Delta AG / \Delta HCO_3^-) is calculated to uncover hidden concurrent metabolic disorders. A ratio greater than 2.0 indicates a superimposed metabolic alkalosis.
Estimated Time:3m 0s
Question 303Question →

A 6262-year-old man comes to the clinic for a routine follow-up. Eight weeks ago, he was hospitalized for new-onset atrial fibrillation and was successfully converted to normal sinus rhythm. He was discharged on a regimen of amiodarone and apixaban. Today, the patient reports feeling well with no palpitations, shortness of breath, heat intolerance, weight changes, fatigue, or constipation. His pulse is 6868/min and regular, and his blood pressure is 124/78124/78 mm Hg. Physical examination shows a normal-sized, non-tender thyroid gland with no palpable nodules. There is no resting tremor.

Laboratory studies show the following:
Thyroid-stimulating hormone (TSH): 7.87.8 μ\mu U/mL (Normal: 0.5−5.00.5-5.0 μ\mu U/mL)
Free thyroxine (T4): 2.12.1 ng/dL (Normal: 0.9−1.70.9-1.7 ng/dL)
Free triiodothyronine (T3): 1.61.6 pg/mL (Normal: 2.3−4.12.3-4.1 pg/mL)

Which of the following is the most appropriate next step in the management of this patient's thyroid function?

Show answer & explanation

Answer: Continue current management and repeat thyroid function tests in 12 weeks

Answer

Continue current management and repeat thyroid function tests in 12 weeks
The correct answer is to continue current management and observe. Amiodarone is an iodine-rich antiarrhythmic drug that exerts multiple physiological effects on the thyroid axis. One of its primary effects is the inhibition of 5'-deiodinase, the enzyme responsible for the peripheral conversion of thyroxine (T4) to the more active triiodothyronine (T3). This inhibition results in an elevation of serum free T4 and a reduction in serum free T3. Because T3 is the primary hormone providing negative feedback to the hypothalamus and pituitary, the transient drop in T3 leads to a compensatory increase in thyroid-stimulating hormone (TSH). This classic physiological profile (mildly elevated TSH, elevated free T4, and low-normal or low free T3) typically peaks within the first 1 to 3 months of amiodarone therapy. Since the patient is entirely asymptomatic and euthyroid, this pattern does not represent true hypothyroidism or thyrotoxicosis. No medical intervention is required, and the TSH will typically normalize over the next 3 to 6 months as a new steady state is achieved.

Step-by-Step Solution

1
Analyze the patient's symptoms and vital signs in the context of his recent medication changes.
The patient is completely asymptomatic, has normal vital signs, and was started on amiodarone 8 weeks ago.
Establishing the clinical status (euthyroid) is crucial before interpreting laboratory abnormalities.
2
Interpret the thyroid function test profile.
The labs show a mildly elevated TSH, an elevated free T4, and a low free T3.
Identifying the specific pattern of hormone alterations helps differentiate between true thyroid disease and medication effects.
3
Correlate the lab profile with the physiological effects of amiodarone.
The pattern matches the expected 5'-deiodinase inhibition caused by amiodarone early in therapy.
Amiodarone predictably decreases peripheral T4 to T3 conversion, leading to transient TSH elevation due to reduced T3-mediated negative feedback.
4
Determine the appropriate clinical intervention.
Observation and repeat testing is selected.
Because these changes are physiologic and the patient is euthyroid, no active medical intervention or drug discontinuation is required.

Key Concept

Early physiologic thyroid function alterations secondary to amiodarone therapy
Estimated Time:1m 30s
Question 304Question →

A 2828-year-old man comes to the clinic with a 55-day history of right knee pain and swelling, accompanied by bilateral eye redness and a burning sensation during urination. He has a medical history of major depressive disorder, for which he takes daily fluoxetine. Four weeks ago, he traveled to Southeast Asia and experienced a self-limited episode of severe watery diarrhea. His temperature is 37.6∘C37.6^\circ\text{C} (99.7∘F99.7^\circ\text{F}), blood pressure is 122/78 mm Hg122/78\text{ mm Hg}, and pulse is 88/min88/\text{min}. Physical examination shows bilateral conjunctival injection with no purulent discharge. The right knee is markedly swollen, warm, and tender to palpation. There is also tenderness over the posterior aspect of the left heel. Arthrocentesis of the right knee yields yellow, translucent synovial fluid with a leukocyte count of 15,000/mm315,000/\text{mm}^3 (50%50\% neutrophils). Gram stain and cultures of the synovial fluid are negative. Polarized light microscopy reveals no crystals.

Laboratory studies show:
Leukocyte count: 11,500/mm311,500/\text{mm}^3
Hemoglobin: 13.8 g/dL13.8\text{ g/dL}
Thyroid-stimulating hormone (TSH): 0.3 \muU/mL0.3\text{ \mu U/mL} (N: 0.50.5–5.0 \muU/mL5.0\text{ \mu U/mL})
Free T4: 0.7 ng/dL0.7\text{ ng/dL} (N: 0.90.9–1.7 ng/dL1.7\text{ ng/dL})

Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Oral naproxen

Answer

Oral naproxen
The correct answer is oral naproxen. This patient's presentation of asymmetric oligoarthritis (knee), enthesitis (Achilles tendinopathy), bilateral conjunctivitis, and urethritis following a severe diarrheal illness is highly characteristic of reactive arthritis. Reactive arthritis is an autoimmune seronegative spondyloarthropathy that develops weeks after an enteric infection (e.g., Campylobacter, Salmonella, Shigella) or a genitourinary infection (e.g., Chlamydia trachomatis). The synovial fluid is inflammatory (typically between 2,000 and 50,000 leukocytes/mm³) but sterile, which is confirmed by the negative Gram stain and culture. First-line therapy for the acute symptomatic management of the arthritis and enthesitis is nonsteroidal anti-inflammatory drugs (NSAIDs), such as naproxen, ibuprofen, or indomethacin.

Step-by-Step Solution

1
Analyze the classic triad of symptoms and the preceding history.
The patient has acute asymmetric oligoarthritis, conjunctivitis, and urethritis occurring 4 weeks after an episode of traveler's diarrhea.
This constellation of symptoms strongly points to reactive arthritis, a seronegative spondyloarthropathy often triggered by enteric infections (e.g., Salmonella, Campylobacter).
2
Evaluate the synovial fluid analysis.
The synovial fluid leukocyte count is 15,000/mm³ with a negative Gram stain and culture.
This confirms an inflammatory etiology (typically 2,000 to 50,000 WBCs/mm³) but rules out an active infectious process (septic arthritis), confirming that the arthritis is a sterile, immune-mediated reaction.
3
Determine the first-line pharmacologic treatment for this condition while considering the patient's current medications.
Nonsteroidal anti-inflammatory drugs (NSAIDs) such as naproxen are indicated.
NSAIDs are the cornerstone of initial therapy for reactive arthritis. Other pain management options like tramadol must be avoided due to the patient's concurrent fluoxetine use.

Key Concept

Reactive arthritis classically presents with a triad of nongonococcal urethritis, asymmetric oligoarthritis, and conjunctivitis following a gastrointestinal or genitourinary infection. The initial treatment of choice is nonsteroidal anti-inflammatory drugs (NSAIDs).
Question 305Question →

Match each clinical presentation in a patient with advanced HIV infection to the most likely central nervous system etiology.

Click a left item, then click its matching right item

Items

A 35-year-old patient with a CD4 count of 80 cells/mm³ presents with fever, seizures, and hemiparesis. Brain MRI reveals multiple ring-enhancing lesions predominantly in the basal ganglia and cerebral cortex.
A 42-year-old patient with a CD4 count of 30 cells/mm³ presents with focal neurologic deficits. Brain MRI demonstrates a solitary, large, weakly ring-enhancing periventricular lesion. Cerebrospinal fluid PCR is positive for Epstein-Barr virus.
A 39-year-old patient with a CD4 count of 45 cells/mm³ develops progressive aphasia, ataxia, and hemiparesis without fever. Brain MRI demonstrates asymmetric, non-enhancing white matter lesions lacking mass effect.
A 45-year-old patient with a CD4 count of 90 cells/mm³ presents with a 2-week history of severe headache, nausea, and photophobia. Lumbar puncture reveals an opening pressure of 320 mm H₂O and encapsulated budding yeast.
A 50-year-old patient with prolonged, untreated HIV infection exhibits progressive memory loss, apathy, and psychomotor slowing over 6 months. Brain MRI shows diffuse cortical atrophy and symmetric periventricular white matter pallor.

Matches

Show answer & explanation

Answer

The correct pairings match each clinical vignette to its corresponding HIV-associated central nervous system complication based on CD4 count thresholds, distinct neuroimaging characteristics, and cerebrospinal fluid findings.
Each diagnosis represents a distinct opportunistic condition in advanced HIV, distinguishable by unique neuroimaging patterns (enhancing vs. non-enhancing, solitary vs. multiple, mass effect vs. no mass effect), focal versus global neurologic symptoms, and specific cerebrospinal fluid analysis findings.

Step-by-Step Solution

1
Analyze the first clinical vignette focusing on CD4 count (< 100 cells/mm³), symptoms (seizures, focal deficits), and MRI findings (multiple ring-enhancing lesions in basal ganglia).
Identified as Toxoplasma gondii encephalitis.
This is the most common cause of focal brain lesions in patients with AIDS, characterized classically by multiple enhancing lesions in the deep white matter and basal ganglia.
2
Analyze the second vignette focusing on the solitary, large periventricular mass and positive CSF Epstein-Barr virus PCR.
Identified as Primary central nervous system lymphoma.
Primary CNS lymphoma in HIV is an AIDS-defining malignancy heavily associated with EBV, presenting typically as a solitary, weakly enhancing periventricular mass.
3
Evaluate the third vignette noting the lack of mass effect, non-enhancing asymmetric white matter lesions, and subacute focal deficits.
Identified as Progressive multifocal leukoencephalopathy.
PML is a demyelinating disease caused by JC virus reactivation, classically appearing on MRI as patchy, non-enhancing white matter lesions without edema or mass effect.
4
Review the fourth vignette recognizing the high CSF opening pressure and presence of encapsulated budding yeast.
Identified as Cryptococcal meningitis.
Cryptococcal neoformans characteristically causes severe meningoencephalitis with highly elevated opening pressures; encapsulated budding yeast is pathognomonic on India ink or histopathology.
5
Assess the final vignette identifying the gradual cognitive decline combined with symmetric atrophy and white matter changes.
Identified as HIV-associated neurocognitive disorder.
HAND (including HIV dementia) presents with progressive cognitive and motor decline; MRI reflects generalized brain volume loss and diffuse, symmetric white matter signal abnormalities without focal lesions.

Key Concept

Differential diagnosis of central nervous system lesions and infections in patients with advanced HIV, utilizing neuroimaging, CD4 count, and CSF analysis.
Estimated Time:2m 0s
Question 306Question →

Match each clinical presentation of a zoonotic or vector-borne infectious disease with the most appropriate targeted antimicrobial therapy.

Click a left item, then click its matching right item

Items

A 30-year-old man from the Northeast United States presents with fever and dark urine; laboratory testing reveals hemolytic anemia, thrombocytopenia, and intraerythrocytic tetrads on a peripheral blood smear.
A 25-year-old woman presents with a tender, enlarged axillary lymph node; she reports adopting a kitten a few weeks ago and has a healing scratch on her ipsilateral hand.
A 35-year-old man recently returned from rural South America presents with fever and unilateral painless periorbital edema; blood microscopy reveals motile trypomastigotes.
A 40-year-old man presents with an ulcerated skin lesion with a dark eschar on his hand and painful regional lymphadenopathy; he recently hunted and skinned a wild rabbit.
A 42-year-old farmer presents with high fever, severe headache, and a nonproductive cough after assisting with sheep parturition; testing shows elevated transaminases and interstitial pneumonia.

Matches

Show answer & explanation

Answer

The correct matches align specific zoonotic and vector-borne clinical syndromes with their definitive antimicrobial therapies: Babesiosis is treated with atovaquone and azithromycin; cat scratch disease with azithromycin; Chagas disease with benznidazole; tularemia with streptomycin; and Q fever with doxycycline.
Each pathogen requires a specific class of antimicrobial based on its unique biology: Babesia (protozoan) requires atovaquone/azithromycin; Bartonella (fastidious bacteria) responds to azithromycin; Trypanosoma (parasite) requires benznidazole; Francisella (Gram-negative coccobacillus) is best treated with aminoglycosides; and Coxiella (intracellular bacteria) requires tetracyclines.

Step-by-Step Solution

1
Identify the etiology for each distinct clinical vignette based on exposure history and physical or laboratory findings.
The vignettes describe Babesiosis, cat scratch disease, Chagas disease, tularemia, and Q fever, respectively.
Accurate pathogen identification is the prerequisite for selecting targeted antimicrobial therapy.
2
Determine the therapy for Babesiosis (hemolytic anemia, intraerythrocytic tetrads).
Match with atovaquone and azithromycin.
This combination effectively targets the intraerythrocytic protozoa while minimizing toxicity.
3
Determine the therapy for cat scratch disease (kitten exposure, regional lymphadenitis).
Match with azithromycin.
A short course of azithromycin accelerates the resolution of Bartonella henselae lymphadenopathy.
4
Determine the therapy for acute Chagas disease (South American travel, Romaña sign).
Match with benznidazole.
Benznidazole (or nifurtimox) is the required therapy for acute Trypanosoma cruzi infection.
5
Determine the therapy for tularemia (rabbit exposure, ulceroglandular disease).
Match with streptomycin.
Aminoglycosides are the gold standard for severe or ulceroglandular Francisella tularensis infection.
6
Determine the therapy for acute Q fever (livestock exposure, atypical pneumonia/hepatitis).
Match with doxycycline.
Doxycycline effectively clears the intracellular pathogen Coxiella burnetii.

Key Concept

Targeted antimicrobial therapy for zoonotic and vector-borne infectious diseases must be selected based on distinct epidemiological exposures and classic clinical manifestations.
Estimated Time:1m 30s
Question 307Question →

Match each clinical presentation of pneumonia or febrile respiratory illness to its most likely causative pathogen based on the provided epidemiological clues and distinct clinical findings.

Click a left item, then click its matching right item

Items

An older male patient with chronic alcohol dependence is evaluated for fever, thick hemoptysis, and radiographic evidence of a right upper lobe cavitary lesion.
A maintenance technician working on a commercial cooling tower develops acute respiratory distress accompanied by loose stools, confusion, and laboratory evidence of severe hyponatremia.
A university dormitory resident seeks care for an unrelenting nonproductive cough, low-grade temperature, and a newly developed rash characterized by target-like macules on both arms.
An exotic bird handler is admitted with a severe headache, photophobia, dry cough, and widespread patchy infiltrates on a chest radiograph.
A livestock farm employee is investigated for a prolonged febrile illness, profound fatigue, elevated liver transaminases, and a normal white blood cell count, notably lacking any cutaneous eruptions.

Matches

Show answer & explanation

Answer

The scenarios match to: Alcohol dependence -> Klebsiella pneumoniae; Cooling tower -> Legionella pneumophila; Dormitory resident with targetoid rash -> Mycoplasma pneumoniae; Bird handler -> Chlamydia psittaci; Livestock worker -> Coxiella burnetii.
The correct pairings align each distinct clinical syndrome and epidemiological exposure with its classic respiratory pathogen. Identifying these unique risk factors—such as avian exposure for psittacosis, contaminated water aerosols for Legionnaires' disease, and livestock exposure for Q fever—is crucial because these organisms dictate specific antimicrobial management that differs from typical community-acquired pneumonia pathways.

Step-by-Step Solution

1
Identify the unique epidemiological risk factor in each patient's history.
Identified exposures: alcohol dependence (aspiration risk), cooling tower (aerosolized water), dormitory (close quarters), bird handling (avian zoonosis), and livestock farm (ruminant zoonosis).
Epidemiological exposures are the primary diagnostic clues for differentiating atypical and specific bacterial pneumonias.
2
Correlate the distinct systemic clinical findings with known pathogen profiles.
Linked thick hemoptysis to lobar necrosis, hyponatremia/diarrhea to systemic infection, targetoid rash to erythema multiforme, and hepatitis without rash to specific zoonoses.
Many of these pathogens present with classic extrapulmonary manifestations that confirm the diagnosis alongside the pulmonary findings.
3
Pair each synthesized clinical and epidemiological profile with the correct pathogen.
The final pairings correctly align the historical and clinical clues to Klebsiella, Legionella, Mycoplasma, C. psittaci, and C. burnetii.
Accurate pathogen identification guides the selection of targeted antimicrobial therapy, such as adding a macrolide or fluoroquinolone for atypical coverage.

Key Concept

Clinical and epidemiological differentiation of atypical and specific lobar pneumonias to guide targeted antimicrobial therapy.
Estimated Time:1m 30s
Question 308Question →

During morning rounds in the intensive care unit, the medical team evaluates a patient recovering from a catheter-associated bloodstream infection. Empiric therapy with intravenous vancomycin and cefepime was initiated three days ago for suspected sepsis. The patient is currently afebrile and hemodynamically stable, and the offending central venous catheter has been removed. Final blood culture results from admission now reveal growth of *Enterococcus faecalis* in two out of two sets. The isolate demonstrates susceptibility to ampicillin, vancomycin, linezolid, and daptomycin. Which of the following is the most appropriate modification to this patient's antimicrobial regimen?

Show answer & explanation

Answer: Discontinue vancomycin and cefepime, and initiate intravenous ampicillin

Answer

Discontinue vancomycin and cefepime, and initiate intravenous ampicillin
The correct approach is to discontinue the broad-spectrum empiric regimen and initiate intravenous ampicillin. For *Enterococcus faecalis* infections that are susceptible to ampicillin, beta-lactam therapy (such as ampicillin or penicillin) is the treatment of choice. Ampicillin is preferred over vancomycin because it is highly active, bactericidal, has a narrower spectrum of activity, and helps prevent the development of vancomycin-resistant enterococci (VRE). De-escalating therapy once culture and susceptibility data are available is a core principle of antibiotic stewardship.

Step-by-Step Solution

1
Identify the pathogen and its susceptibility profile from the blood culture results.
The pathogen is *Enterococcus faecalis*, which is susceptible to ampicillin, vancomycin, linezolid, and daptomycin.
Correct identification and susceptibility testing are required to transition from empiric to targeted therapy.
2
Determine the optimal targeted therapy for susceptible *Enterococcus*.
Ampicillin is the drug of choice for susceptible *Enterococcus faecalis* due to its bactericidal activity and narrow spectrum.
Beta-lactams are preferred over vancomycin for susceptible isolates to ensure optimal efficacy and minimize resistance.
3
Apply principles of antimicrobial stewardship to the current regimen.
The overly broad empiric agents (vancomycin and cefepime) should be discontinued, and targeted therapy with intravenous ampicillin should be initiated.
De-escalating therapy reduces the risk of adverse effects, lowers costs, and prevents the emergence of multidrug-resistant organisms.

Key Concept

Antimicrobial Stewardship and Enterococcal Bacteremia Management
Question 309Question →

An outpatient evaluation is conducted for a 3535-year-old female patient who reports severe fatigue and feeling constantly cold. Over the past 66 months, she has noticed a 5-kg5\text{-kg} (11-lb11\text{-lb}) weight gain despite a poor appetite, and her menstrual cycles have completely stopped. She has no chronic medical conditions and takes no medications. Vital signs show a temperature of 36.2∘C36.2^\circ\text{C} (97.2∘F97.2^\circ\text{F}), blood pressure of 108/68 mm Hg108/68 \text{ mm Hg}, and pulse of 52/min52/\text{min}. Physical examination reveals dry skin, delayed relaxation of the deep tendon reflexes, and no palpable thyroid enlargement. Visual fields are full to confrontation. Laboratory results are as follows:

Thyroid-stimulating hormone (TSH): 0.1 mU/L0.1 \text{ mU/L} (Normal: 0.4−4.0 mU/L0.4 - 4.0 \text{ mU/L})
Free thyroxine (T4): 0.4 ng/dL0.4 \text{ ng/dL} (Normal: 0.9−1.7 ng/dL0.9 - 1.7 \text{ ng/dL})

Which of the following is the most likely underlying cause of this patient's clinical presentation?

Show answer & explanation

Answer: Anterior pituitary adenoma

Answer

The most likely diagnosis is an anterior pituitary adenoma, which causes secondary hypothyroidism and hypogonadotropic hypogonadism.
The correct answer accurately synthesizes the laboratory data (low free T4 and low TSH) to localize the defect to the central nervous system (pituitary or hypothalamus) rather than the thyroid gland itself. The concurrent history of amenorrhea makes an anterior pituitary adenoma the most likely unifying diagnosis, as expanding pituitary lesions frequently compress adjacent normal pituitary tissue, leading to multiple anterior pituitary hormone deficiencies (panhypopituitarism).

Step-by-Step Solution

1
Interpret the clinical symptoms and vital signs.
The patient exhibits weight gain, fatigue, cold intolerance, delayed reflexes, and bradycardia, establishing a clinical hypothyroid state.
Initial pattern recognition of the metabolic state directs further laboratory analysis.
2
Analyze the thyroid function laboratory tests.
The free T4 is low, confirming hypothyroidism, while the TSH is inappropriately low. This combination rules out a primary thyroid gland defect and indicates central (secondary) hypothyroidism.
The relationship between TSH and T4 determines the anatomical location of the defect in the hypothalamic-pituitary-thyroid axis.
3
Correlate the laboratory diagnosis with the secondary symptom of amenorrhea.
The combination of central hypothyroidism and amenorrhea points to a widespread disruption of the anterior pituitary gland.
A pituitary adenoma can cause a mass effect or hyperprolactinemia, which simultaneously disrupts the secretion of both TSH and gonadotropins (FSH/LH).

Key Concept

Secondary (central) hypothyroidism is characterized by a low free T4 and a low or inappropriately normal TSH. When accompanied by other pituitary hormone deficiencies (such as amenorrhea), it strongly suggests a pituitary lesion like an adenoma.
Estimated Time:50s
Question 310Question →

A 32-year-old woman is evaluated in the clinic for progressive generalized muscle weakness and fatigue over the past three weeks. She has a past medical history of two episodes of nephrolithiasis in the last three years but takes no daily medications. She reports no recent history of diarrhea, vomiting, or dietary changes. Her temperature is 37.0°C37.0°\text{C} (98.6°F98.6°\text{F}), blood pressure is 112/72 mm Hg112/72 \text{ mm Hg}, pulse is 82/min82/\text{min}, and respiratory rate is 18/min18/\text{min}. Physical examination reveals decreased deep tendon reflexes globally but is otherwise unremarkable.

Laboratory results are as follows:

TestResultReference Range
Sodium (Na+Na^+)140 mEq/L140 \text{ mEq/L}136−145 mEq/L136-145 \text{ mEq/L}
Potassium (K+K^+)2.7 mEq/L2.7 \text{ mEq/L}3.5−5.0 mEq/L3.5-5.0 \text{ mEq/L}
Chloride (Cl−Cl^-)116 mEq/L116 \text{ mEq/L}95−105 mEq/L95-105 \text{ mEq/L}
Bicarbonate (HCO3−HCO_3^-)14 mEq/L14 \text{ mEq/L}22−28 mEq/L22-28 \text{ mEq/L}
Blood urea nitrogen12 mg/dL12 \text{ mg/dL}7−18 mg/dL7-18 \text{ mg/dL}
Creatinine0.9 mg/dL0.9 \text{ mg/dL}0.6−1.2 mg/dL0.6-1.2 \text{ mg/dL}

Arterial blood gas (room air):

TestResultReference Range
pH7.277.277.35−7.457.35-7.45
PaCO2PaCO_229 mm Hg29 \text{ mm Hg}35−45 mm Hg35-45 \text{ mm Hg}
PaO2PaO_296 mm Hg96 \text{ mm Hg}75−105 mm Hg75-105 \text{ mm Hg}

Urinalysis reveals a pH of 6.5, specific gravity of 1.015, and is negative for protein, blood, and glucose.

Based on the clinical presentation and laboratory findings, which of the following best describes this patient's underlying condition and acid-base status?

Show answer & explanation

Answer: Normal anion gap metabolic acidosis with appropriate respiratory compensation due to a distal tubular defect

Answer

Normal anion gap metabolic acidosis with appropriate respiratory compensation due to a distal tubular defect
The patient's laboratory results demonstrate a normal anion gap metabolic acidosis (NAGMA) with appropriate respiratory compensation, secondary to Type 1 (distal) renal tubular acidosis (RTA). A step-wise evaluation reveals acidemia (pH 7.27) with a low bicarbonate (14 mEq/L14 \text{ mEq/L}), signifying metabolic acidosis. The anion gap is normal at 10 mEq/L10 \text{ mEq/L}. Using Winter's formula, the expected PaCO2PaCO_2 is calculated as 1.5×14+8=29±2 mm Hg1.5 \times 14 + 8 = 29 \pm 2 \text{ mm Hg}. Because the actual PaCO2PaCO_2 is exactly 29 mm Hg29 \text{ mm Hg}, the respiratory compensation is fully appropriate, meaning there is no mixed acid-base disorder. The underlying etiology is a distal tubular defect (Type 1 RTA), which is clinically characterized by severe hypokalemia, the inability to acidify urine below a pH of 5.5 (patient's urine pH is 6.5), and a high risk of calcium phosphate kidney stones forming in the alkaline urine.

Step-by-Step Solution

1
Identify the primary acid-base disturbance by evaluating the arterial pH and serum bicarbonate.
The low pH (7.277.27) and low serum bicarbonate (14 mEq/L14 \text{ mEq/L}) confirm a primary metabolic acidosis.
Establishing the primary disturbance directs the subsequent steps of the diagnostic algorithm.
2
Calculate the serum anion gap (AG) to classify the etiology of the metabolic acidosis.
The calculated AG is [Na+]−([Cl−]+[HCO3−])=140−(116+14)=10 mEq/L[Na^+] - ([Cl^-] + [HCO_3^-]) = 140 - (116 + 14) = 10 \text{ mEq/L}, which falls within the normal range (10−14 mEq/L10-14 \text{ mEq/L}).
Differentiating between a normal and high anion gap significantly narrows the differential diagnosis.
3
Apply Winter's formula to determine if the respiratory compensation is appropriate or if a mixed disorder is present.
Expected PaCO2=1.5×[HCO3−]+8±2=1.5×14+8±2=29±2 mm HgPaCO_2 = 1.5 \times [HCO_3^-] + 8 \pm 2 = 1.5 \times 14 + 8 \pm 2 = 29 \pm 2 \text{ mm Hg}. The patient's actual PaCO2PaCO_2 is 29 mm Hg29 \text{ mm Hg}, confirming perfect respiratory compensation with no secondary respiratory disorder.
Failure to accurately calculate the expected compensatory response frequently leads to the misdiagnosis of a mixed acid-base disorder.
4
Determine the specific cause of the normal anion gap metabolic acidosis based on clinical history, serum potassium, and urine pH.
The presence of severe hypokalemia (2.7 mEq/L2.7 \text{ mEq/L}), an inappropriately alkaline urine (pH 6.56.5) despite systemic acidemia, and a history of nephrolithiasis strongly point to Type 1 (distal) renal tubular acidosis.
These findings reflect the specific pathophysiological defect of impaired distal tubular hydrogen ion secretion, which inherently prevents proper urine acidification and predisposes to calcium phosphate stone formation.

Key Concept

Type 1 (distal) renal tubular acidosis presents as a normal anion gap metabolic acidosis with hypokalemia, an inappropriately alkaline urine (pH > 5.5) despite systemic acidemia, and a strong predisposition to calcium phosphate nephrolithiasis.
Estimated Time:1m 30s
Question 311Question →

A 3838-year-old man is brought to the emergency department due to a severe nosebleed that has not stopped for 22 hours, along with bleeding gums and profound fatigue over the past week. His temperature is 37.8∘C37.8^\circ\text{C} (100.0∘F100.0^\circ\text{F}), blood pressure is 110/70110/70 mm Hg, and heart rate is 112112/min. Physical examination reveals diffuse petechiae across his chest and large ecchymoses on his extremities. Laboratory studies show:

Complete Blood CountValue
Hemoglobin8.28.2 g/dL
Leukocyte count2,100/mm32,100/\text{mm}^3
Platelet count18,000/mm318,000/\text{mm}^3
Coagulation ProfileValue
Prothrombin time (PT)2222 seconds
Activated partial thromboplastin time (aPTT)5555 seconds
Fibrinogen7575 mg/dL
D-dimer>10,000>10,000 ng/mL

A peripheral blood smear reveals pancytopenia and several large, atypical promyelocytes containing multiple needle-like intracytoplasmic inclusions.

Arrange the following steps in the most appropriate chronological order for the optimal management of this patient's condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: 1) Empirical administration of all-trans retinoic acid (ATRA), 2) Bone marrow aspiration and biopsy, 3) Molecular confirmation of the PML::RARA fusion gene, 4) Addition of arsenic trioxide (ATO) to the treatment regimen.
Acute promyelocytic leukemia (APL) is a medical emergency that presents with pancytopenia and severe coagulopathy (DIC), driven by the release of procoagulants from leukemic promyelocytes. The first and most critical step is the empirical administration of all-trans retinoic acid (ATRA). ATRA induces differentiation of the malignant promyelocytes into mature neutrophils, which rapidly halts the coagulopathy and prevents fatal bleeding. Because of the high risk of early mortality from hemorrhage, ATRA must be given as soon as APL is suspected based on peripheral smear morphology (e.g., atypical promyelocytes with Auer rods), without waiting for definitive diagnostic tests. After ATRA is initiated and supportive care (e.g., cryoprecipitate, platelets) is provided, a bone marrow aspiration and biopsy is performed. The obtained marrow sample is then used for molecular confirmation via FISH or PCR to identify the pathognomonic t(15;17) translocation (PML::RARA fusion gene). Once the diagnosis is definitively confirmed and the patient's risk profile is established, arsenic trioxide (ATO) and/or chemotherapy is added to ATRA to complete the definitive induction treatment regimen.

Step-by-Step Solution

1
Recognize the clinical presentation of Acute Promyelocytic Leukemia (APL).
The patient has pancytopenia, bleeding, DIC (low fibrinogen, elevated PT/aPTT/D-dimer), and atypical promyelocytes with Auer rods (needle-like inclusions).
Identifying APL is critical because it is a hematologic emergency requiring immediate specific intervention.
2
Determine the immediate next step in management.
Empirical initiation of ATRA is required as the very first step.
ATRA promotes differentiation of the leukemic promyelocytes, rapidly reversing the severe coagulopathy and preventing fatal hemorrhage. It must not be delayed for confirmatory testing.
3
Identify the proper sequence of diagnostic confirmation.
Bone marrow biopsy is performed to obtain the necessary sample, followed by molecular testing (FISH/PCR) on that sample.
Definitive diagnosis requires identifying the t(15;17) translocation, but the tissue must first be safely collected via biopsy.
4
Determine the definitive treatment step.
Add ATO (and sometimes anthracyclines, depending on risk stratification) to complete the induction regimen.
Once the diagnosis is genetically confirmed and risk is stratified, standard definitive induction therapy is implemented.

Key Concept

In patients with suspected acute promyelocytic leukemia (APL), all-trans retinoic acid (ATRA) must be initiated immediately to prevent fatal hemorrhage from disseminated intravascular coagulation (DIC), prior to obtaining a bone marrow biopsy and awaiting molecular confirmation.
Estimated Time:1m 30s
Question 312Question →

An endocrinologist is reviewing the results of 72-hour fasting tests for five adult patients who developed neuroglycopenic symptoms with concurrent plasma glucose levels < 50 mg/dL. Match each patient's specific plasma laboratory profile, drawn at the precise time of symptomatic hypoglycemia, to the most likely underlying pathophysiologic etiology.

Click a left item, then click its matching right item

Items

Insulin markedly elevated, C-peptide suppressed, beta-hydroxybutyrate suppressed, oral hypoglycemic screen negative
Insulin elevated, C-peptide elevated, proinsulin disproportionately elevated, beta-hydroxybutyrate suppressed, oral hypoglycemic screen negative
Insulin elevated, C-peptide elevated, proinsulin normal, beta-hydroxybutyrate suppressed, oral hypoglycemic screen positive
Insulin suppressed, C-peptide suppressed, beta-hydroxybutyrate suppressed, IGF-II to IGF-I ratio > 10
Insulin suppressed, C-peptide suppressed, beta-hydroxybutyrate markedly elevated, serum cortisol < 3 µg/dL

Matches

Show answer & explanation

Answer

The laboratory profiles uniquely differentiate the mechanisms of fasting hypoglycemia based on endogenous insulin secretion (C-peptide), beta-cell maturation (proinsulin), alternative insulin-receptor agonists (IGF-II), secretagogue presence, and the ketotic versus non-ketotic nature of the hypoglycemia.
Each laboratory profile distinctly aligns with a specific pathophysiologic mechanism of hypoglycemia. Factitious exogenous insulin provides the hormone without C-peptide. Insulinomas secrete mature insulin, C-peptide, and large amounts of proinsulin autonomously. Sulfonylureas drive normal endogenous secretion (increasing both insulin and C-peptide). NICTH relies on IGF-II activating insulin receptors systemically, which suppresses true insulin, C-peptide, and ketones. Finally, adrenal insufficiency causes hypoglycemia via impaired gluconeogenesis; the resulting appropriately suppressed insulin allows for unimpeded ketogenesis.

Step-by-Step Solution

1
Analyze insulin and C-peptide levels to differentiate exogenous from endogenous hyperinsulinism.
High insulin with suppressed C-peptide indicates an exogenous source, while high insulin with elevated C-peptide indicates an endogenous source.
C-peptide is co-secreted with endogenous insulin in equimolar amounts but is absent in pharmaceutical insulin preparations.
2
Differentiate endogenous hyperinsulinism etiologies using drug screens and proinsulin levels.
A positive screen confirms secretagogue use; a negative screen with disproportionately high proinsulin strongly points to an insulinoma.
Beta-cell neoplasms are less efficient at processing proinsulin to mature insulin compared to healthy beta cells stimulated by drugs.
3
Evaluate beta-hydroxybutyrate (ketone) levels to determine if the hypoglycemia is insulin-mediated.
Suppressed ketones indicate active suppression of lipolysis by an insulin-like effect (hyperinsulinism or IGF-II), whereas high ketones indicate appropriate insulin suppression (e.g., hypocortisolism).
Insulin strongly inhibits hormone-sensitive lipase, preventing ketone body formation.

Key Concept

Differential diagnosis of adult fasting hypoglycemia using the 72-hour fasting test.
Question 313Question →

Match each patient's clinical presentation with the most appropriate confirmatory diagnostic test.

Click a left item, then click its matching right item

Items

A 35-year-old woman with a history of systemic lupus erythematosus presents with worsening fatigue and scleral icterus. Labs show a hemoglobin of 7.8 g/dL, mean corpuscular volume of 105 fL, and an elevated reticulocyte production index. Peripheral smear reveals microspherocytes.
A 52-year-old man is evaluated for progressive fatigue and intermittent morning dark urine. He recently developed acute abdominal pain, and imaging confirmed thrombosis of the portal and mesenteric veins. Complete blood count shows pancytopenia.
A 22-year-old man is treated with nitrofurantoin for uncomplicated cystitis. Three days later, he develops sudden-onset jaundice, back pain, and hemoglobinuria. Peripheral smear shows eccentrocytes and bite cells.
A 15-year-old boy presents with right upper quadrant pain. Ultrasound reveals multiple pigment gallstones. Physical examination is notable for splenomegaly. His father had a cholecystectomy at age 25. Labs show an elevated mean corpuscular hemoglobin concentration (MCHC).
A 45-year-old woman presents to the emergency department with altered mental status and fever. Laboratory evaluation reveals a platelet count of 22,000/mm³, hemoglobin of 8.2 g/dL, creatinine of 2.1 mg/dL, and elevated lactate dehydrogenase. Schistocytes are prominent on the peripheral smear.

Matches

Show answer & explanation

Answer

The presentations match as follows: SLE with spherocytes matches Direct antiglobulin test; Pancytopenia with portal vein thrombosis matches Flow cytometry for CD55 and CD59; Hemolysis post-nitrofurantoin matches G6PD enzyme assay; Pigment gallstones with high MCHC matches EMA binding test; Altered mental status with schistocytes matches ADAMTS13 activity assay.
Each clinical presentation contains classic pathognomonic findings that map to a highly specific diagnostic test for a particular hematologic disorder. The SLE patient with spherocytes has AIHA (Direct Coombs). The patient with pancytopenia and portal vein thrombosis has PNH (CD55/CD59). The patient with acute hemolysis after nitrofurantoin has G6PD deficiency (G6PD assay). The adolescent with pigment gallstones and high MCHC has hereditary spherocytosis (EMA binding). The patient with schistocytes, thrombocytopenia, and confusion has TTP (ADAMTS13).

Step-by-Step Solution

1
Analyze the first clinical presentation
SLE patient with hemolysis and spherocytes suggests warm autoimmune hemolytic anemia.
Systemic autoimmune diseases often produce IgG autoantibodies directed against red blood cell antigens.
2
Analyze the second clinical presentation
Pancytopenia, atypical venous thrombosis, and hemolysis point to paroxysmal nocturnal hemoglobinuria (PNH).
An acquired stem cell mutation leads to a lack of GPI anchors, making red blood cells highly susceptible to complement-mediated destruction.
3
Analyze the third clinical presentation
Hemolysis after a classic trigger (nitrofurantoin) with bite cells indicates Glucose-6-phosphate dehydrogenase deficiency.
Decreased NADPH production leads to oxidative damage of hemoglobin when exposed to specific medications or infections.
4
Analyze the fourth clinical presentation
A young patient with pigment gallstones, splenomegaly, and high MCHC suggests hereditary spherocytosis.
An inherited structural membrane defect leads to red blood cell dehydration, increasing the MCHC and causing splenic destruction.
5
Analyze the fifth clinical presentation
Thrombocytopenia, schistocytes, renal injury, and neurologic changes classically describe thrombotic thrombocytopenic purpura (TTP).
Microthrombi form systemically due to uncleaved, ultra-large von Willebrand factor multimers.

Key Concept

Clinical presentations and confirmatory diagnostics of hemolytic anemias and thrombotic microangiopathies
Question 314Question →

Match each patient's clinical presentation with the most likely predominant finding on their peripheral blood smear.

Click a left item, then click its matching right item

Items

A 68-year-old man with massive splenomegaly, early satiety, and a 'dry tap' on bone marrow aspiration.
A 24-year-old woman with intermittent jaundice, splenomegaly, and a family history of gallstones at a young age.
A 35-year-old woman with severe epistaxis, widespread ecchymoses, and laboratory evidence of disseminated intravascular coagulation.
A 65-year-old man with generalized, painless cervical lymphadenopathy and an absolute lymphocyte count of 45,000/µL.

Matches

Show answer & explanation

Answer

Primary myelofibrosis correlates with teardrop cells; hereditary spherocytosis correlates with spherocytes lacking central pallor; acute promyelocytic leukemia correlates with Auer rods; and chronic lymphocytic leukemia correlates with smudge cells.
Each clinical presentation contains classic pathognomonic features that align with a specific peripheral blood smear finding. Understanding the underlying pathophysiology (e.g., marrow fibrosis, membrane defects, granule release, or cell fragility) allows for accurate pairing of the disease state to its microscopic appearance.

Step-by-Step Solution

1
Evaluate the first vignette describing an older adult with massive splenomegaly and a dry bone marrow tap.
Identify the diagnosis as primary myelofibrosis.
Marrow fibrosis leads to a leukoerythroblastic smear with teardrop cells due to the mechanical stress on red blood cells exiting the marrow.
2
Evaluate the second vignette describing a young adult with hemolytic anemia symptoms and early gallstones.
Identify the diagnosis as hereditary spherocytosis.
Cytoskeletal membrane defects lead to the formation of spherocytes, which are prematurely destroyed in the spleen.
3
Evaluate the third vignette describing a patient with sudden onset of bleeding and DIC.
Identify the diagnosis as acute promyelocytic leukemia (APL).
The release of procoagulants from the primary granules (Auer rods) inside the neoplastic promyelocytes triggers DIC.
4
Evaluate the fourth vignette describing an older adult with prominent lymphocytosis and lymphadenopathy.
Identify the diagnosis as chronic lymphocytic leukemia (CLL).
The malignant lymphocytes in CLL are physically delicate, leading to the artifactual appearance of smudge cells on the peripheral smear.

Key Concept

Recognizing specific morphological abnormalities on a peripheral blood smear is essential for diagnosing various hematologic malignancies and intrinsic red blood cell disorders.
Estimated Time:1m 30s
Question 315Question →

A 6868-year-old man is hospitalized due to a 44-week history of fatigue, intermittent fevers, and unintentional weight loss. Two months ago, he underwent a cystoscopy for evaluation of hematuria. His temperature is 38.2∘C38.2^\circ\text{C} (100.8∘F100.8^\circ\text{F}), pulse is 92/min92/\text{min}, and blood pressure is 118/74 mm Hg118/74\text{ mm Hg}. Physical examination reveals small, linear, dark red streaks in the nail beds of both hands and a new grade 3/63/6 holosystolic murmur heard best at the cardiac apex.

Echocardiography demonstrates a 1.2-cm1.2\text{-cm} mobile vegetation on the mitral valve with moderate mitral regurgitation.

Laboratory studies show:
Leukocyte count: 14,500/mm314,500/\text{mm}^3
Serum creatinine: 2.2 mg/dL2.2\text{ mg/dL} (baseline: 1.0 mg/dL1.0\text{ mg/dL})

Three sets of blood cultures are drawn, and the patient is started empirically on intravenous vancomycin and piperacillin-tazobactam. Forty-eight hours later, all blood culture bottles grow *Enterococcus faecalis*. Susceptibility testing reveals:

Ampicillin: Susceptible
Vancomycin: Susceptible
Piperacillin-tazobactam: Susceptible
Gentamicin: High-level resistance

Which of the following is the most appropriate targeted pharmacotherapy for this patient?

Show answer & explanation

Answer: Intravenous ampicillin and intravenous ceftriaxone

Answer

Intravenous ampicillin and intravenous ceftriaxone
The correct targeted therapy is the combination of intravenous ampicillin and intravenous ceftriaxone. This patient has *Enterococcus faecalis* native valve infective endocarditis following a genitourinary procedure. Enterococci are intrinsically tolerant to many antibiotics; therefore, endocarditis treatment requires a synergistic, bactericidal regimen. While ampicillin plus an aminoglycoside (like gentamicin) is a traditional regimen, this patient's isolate demonstrates high-level gentamicin resistance (HLGR), which abolishes the synergistic effect. Additionally, the patient has acute kidney injury, making nephrotoxic agents contraindicated. The combination of ampicillin and ceftriaxone provides excellent bactericidal synergy through complementary binding of different penicillin-binding proteins (PBPs), effectively bypassing the need for aminoglycosides, and is the standard of care for HLGR *E. faecalis* endocarditis.

Step-by-Step Solution

1
Diagnose the primary condition based on clinical and echocardiographic findings.
The patient has native valve infective endocarditis (IE), evidenced by fever, splinter hemorrhages, a new mitral murmur, and a valvular vegetation on echocardiography.
Identifying the deep-seated nature of the infection is crucial, as IE requires prolonged, bactericidal therapy rather than bacteriostatic drugs.
2
Identify the pathogen and interpret the susceptibility profile.
The causative organism is Enterococcus faecalis. The susceptibility panel shows it is sensitive to ampicillin but has high-level gentamicin resistance (HLGR).
E. faecalis typically requires synergistic therapy for endocarditis. HLGR indicates that adding an aminoglycoside will not produce the required bactericidal synergy.
3
Select the optimal targeted antibiotic regimen considering patient comorbidities.
Intravenous ampicillin plus intravenous ceftriaxone is selected.
This combination provides dual beta-lactam synergy, which is bactericidal and highly effective against HLGR strains. It also avoids the nephrotoxicity of aminoglycosides, which is essential given the patient's acute kidney injury (creatinine 2.2 mg/dL).

Key Concept

Treatment of Enterococcus faecalis infective endocarditis requires bactericidal synergy. For isolates with high-level aminoglycoside resistance or in patients with renal impairment, the combination of ampicillin and ceftriaxone is the first-line targeted therapy.
Question 316Question →

An evaluation is requested for a 32-year-old woman who reports profound fatigue, cold intolerance, and a 55-kg (1111-lb) weight gain over the past six months. She also notes that her menstrual cycles have not resumed since the vaginal delivery of her first child 10 months ago. The patient's medical records indicate that her delivery was complicated by uterine atony and severe postpartum hemorrhage requiring the transfusion of four units of packed red blood cells. Following the birth, she was unable to breastfeed despite multiple attempts.

Vital signs include a blood pressure of 88/5688/56 mm Hg and a heart rate of 5858/min. Physical examination demonstrates pale, dry skin and a noticeable loss of axillary and pubic hair. Deep tendon reflexes show delayed relaxation.

Laboratory studies reveal:
Thyroid-stimulating hormone (TSH): 1.31.3 μ\mu U/mL (Normal: 0.50.5-5.05.0 μ\mu U/mL)
Free thyroxine (T4): 0.40.4 ng/dL (Normal: 0.90.9-1.71.7 ng/dL)

Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Measure early morning serum cortisol

Answer

Measure early morning serum cortisol
The correct answer is to measure early morning serum cortisol. This patient's history of severe postpartum hemorrhage followed by failure to lactate, amenorrhea, and loss of pubic hair is highly characteristic of Sheehan syndrome (ischemic necrosis of the pituitary gland). This leads to panhypopituitarism, including central hypothyroidism and central adrenal insufficiency. Her laboratory results (low free T4 with inappropriately normal TSH) confirm central hypothyroidism. In any patient with suspected panhypopituitarism, the adrenal axis must be evaluated (via 8 AM serum cortisol) before initiating thyroid hormone replacement. Levothyroxine increases the basal metabolic rate and hepatic clearance of cortisol; if administered to a patient with unrecognized and untreated adrenal insufficiency, it can precipitate a life-threatening acute adrenal crisis. Therefore, glucocorticoid replacement must always precede thyroid hormone replacement.

Step-by-Step Solution

1
Analyze the patient's clinical history.
The history of severe postpartum hemorrhage, subsequent failure to lactate, amenorrhea, and loss of pubic hair points to Sheehan syndrome (postpartum ischemic necrosis of the anterior pituitary).
Identifying the underlying condition provides context for interpreting the laboratory results and prioritizing management.
2
Interpret the thyroid laboratory findings.
The patient has a markedly low free T4 with an inappropriately normal TSH, which confirms the diagnosis of central hypothyroidism.
Differentiating primary from central hypothyroidism is crucial for understanding the extent of the endocrine dysfunction.
3
Determine the most critical next step in management.
The most appropriate next step is to measure an early morning serum cortisol to evaluate for concurrent central adrenal insufficiency.
In panhypopituitarism, thyroid hormone replacement can increase the metabolic clearance of cortisol. If adrenal insufficiency is present and not treated first with glucocorticoids, starting levothyroxine can precipitate a fatal acute adrenal crisis.

Key Concept

In patients with suspected panhypopituitarism, assessment of the adrenal axis (e.g., serum cortisol) and appropriate glucocorticoid replacement MUST precede the initiation of thyroid hormone replacement to avoid precipitating an acute adrenal crisis.
Question 317Question →

A 5454-year-old woman arrives at the emergency department with severe, sudden-onset breathing difficulty that started one hour ago. The patient has a history of long-standing hypertension but has not taken her prescribed medications for several months.

On evaluation, she is sitting upright, diaphoretic, and in significant respiratory distress.

Vital signs show a temperature of 37.0∘C37.0^\circ\text{C} (98.6∘F98.6^\circ\text{F}), blood pressure of 220/115 mm Hg220/115\text{ mm Hg}, heart rate of 118/min118/\text{min}, and respiratory rate of 28/min28/\text{min}. Oxygen saturation is 88%88\% on room air.

Physical examination reveals prominent jugular venous distention. Pulmonary auscultation demonstrates bilateral crackles extending to the apices and widespread expiratory wheezing.

Cardiac auscultation reveals a regular tachycardia and a prominent fourth heart sound (S4). There is no peripheral edema.

Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Intravenous furosemide and nitroglycerin

Answer

Intravenous furosemide and nitroglycerin
The correct answer provides rapid preload and afterload reduction. The patient's clinical presentation—severe hypertension, hypoxia, diffuse crackles, jugular venous distention, and an S4 gallop—is classic for acute decompensated heart failure presenting as flash pulmonary edema. The rapid rise in blood pressure severely increases left ventricular afterload, leading to acute left ventricular failure and fluid back-up into the pulmonary vasculature. The most appropriate initial management involves prompt blood pressure control and volume offloading with intravenous nitroglycerin and a loop diuretic such as furosemide.

Step-by-Step Solution

1
Identify the primary clinical syndrome.
The patient has severe hypertension, hypoxia, jugular venous distention, S4 gallop, and diffuse crackles, indicating acute decompensated heart failure presenting as flash pulmonary edema.
Recognizing the syndrome rapidly limits the differential diagnosis and dictates immediate, life-saving management.
2
Determine the optimal acute pharmacological intervention.
Select agents that rapidly reduce both preload and afterload.
Intravenous nitroglycerin quickly lowers blood pressure (afterload) and venous return (preload), while an intravenous loop diuretic removes excess fluid volume.

Key Concept

Flash pulmonary edema in the setting of hypertensive emergency requires rapid preload and afterload reduction, typically with intravenous nitroglycerin and a loop diuretic.
Question 318Question →

Match each physical examination finding and its corresponding response to dynamic auscultatory maneuvers with the most likely underlying structural or valvular pathology.

Click a left item, then click its matching right item

Items

Harsh crescendo-decrescendo systolic murmur that becomes louder during the strain phase of the Valsalva maneuver
Systolic ejection murmur at the right upper sternal border that becomes louder with rapid squatting and softer with standing
Systolic murmur preceded by a mid-systolic click that moves closer to the first heart sound (S1S_1) upon standing
High-pitched, blowing, early diastolic murmur that becomes louder with sustained handgrip

Matches

Show answer & explanation

Answer

The physical examination findings map to their physiological responses: Valsalva increases HOCM murmurs by decreasing preload, squatting increases AS murmurs by increasing forward flow, standing moves the MVP click earlier by decreasing LV volume, and handgrip increases AR murmurs by elevating afterload.
Each structural defect responds to hemodynamic changes according to its underlying pathophysiology. Hypertrophic obstructive cardiomyopathy and mitral valve prolapse are primarily affected by left ventricular volume (worsening with decreased preload). Aortic stenosis depends on flow across the valve (worsening with increased preload/stroke volume). Aortic regurgitation is driven by the pressure gradient across the incompetent valve (worsening with increased afterload).

Step-by-Step Solution

1
Evaluate the effect of the Valsalva maneuver on a crescendo-decrescendo murmur.
Valsalva decreases preload, which makes the murmur louder. This points directly to hypertrophic obstructive cardiomyopathy.
Decreased left ventricular volume worsens the dynamic left ventricular outflow tract obstruction.
2
Evaluate the effect of rapid squatting on a systolic ejection murmur.
Squatting increases preload, increasing stroke volume, which makes the murmur louder. This is characteristic of aortic valve stenosis.
More blood flowing across a fixed stenotic valve generates a louder murmur.
3
Evaluate the effect of standing on a click and murmur.
Standing decreases preload, moving the click closer to S1S_1. This indicates mitral valve prolapse.
A smaller ventricular volume allows the redundant leaflets to prolapse earlier during systole.
4
Evaluate the effect of sustained handgrip on a diastolic murmur.
Handgrip increases afterload, making the murmur louder. This identifies aortic valve regurgitation.
Higher systemic vascular resistance increases the pressure gradient driving regurgitant flow backward into the left ventricle.

Key Concept

Dynamic auscultation utilizes physiologic maneuvers (such as standing, squatting, handgrip, and Valsalva) to alter preload and afterload, helping to differentiate underlying structural and valvular heart defects based on predictable changes in murmur intensity and timing.
Question 319Question →

A 34-year-old man with a history of intravenous opioid use disorder is hospitalized for a 1-week history of fever, chills, and pleuritic chest pain. On admission, multiple sets of blood cultures are drawn, and empiric intravenous vancomycin and cefepime are initiated. A transthoracic echocardiogram reveals a 1.4-cm1.4\text{-cm} mobile vegetation on the tricuspid valve with moderate tricuspid regurgitation. Two days later, all blood culture bottles grow *Staphylococcus aureus*. Susceptibility testing indicates the isolate is resistant to penicillin G, but susceptible to oxacillin, cefazolin, and vancomycin. The patient's medical record notes a history of a diffuse maculopapular rash after taking amoxicillin for a respiratory infection 5 years ago; he specifically denies any history of facial swelling, difficulty breathing, or anaphylaxis associated with medications. His temperature is currently 37.6∘C37.6^\circ\text{C} (99.7∘F99.7^\circ\text{F}), blood pressure is 122/76 mm Hg122/76\text{ mm Hg}, and heart rate is 82/min82/\text{min}. Which of the following is the most appropriate next step in the pharmacologic management of this patient?

Show answer & explanation

Answer: Discontinue vancomycin and cefepime, and initiate intravenous cefazolin.

Answer

Discontinue vancomycin and cefepime, and initiate intravenous cefazolin.
The correct answer is to discontinue vancomycin and cefepime, and initiate intravenous cefazolin. This patient has right-sided native valve infective endocarditis caused by methicillin-susceptible *Staphylococcus aureus* (MSSA), as proven by the isolate's susceptibility to oxacillin. For MSSA bacteremia and endocarditis, definitive, targeted therapy with a beta-lactam antibiotic (such as cefazolin, nafcillin, or oxacillin) is vastly superior to vancomycin, demonstrating more rapid bacterial clearance, lower rates of relapse, and reduced overall mortality. Although the patient has a reported penicillin allergy, his reaction (a delayed maculopapular rash) was non-severe and not IgE-mediated (i.e., no anaphylaxis, angioedema, or bronchospasm). First-generation cephalosporins like cefazolin have a distinct side-chain structure and a negligible risk of cross-reactivity in patients with non-anaphylactic penicillin allergies, making them extremely safe and highly preferred in this scenario. De-escalating from broad-spectrum empiric therapy strictly aligns with the core principles of antibiotic stewardship.

Step-by-Step Solution

1
Identify the causative organism and its resistance profile from the blood culture data.
The blood cultures grew Staphylococcus aureus that is susceptible to oxacillin, confirming it is methicillin-susceptible S. aureus (MSSA).
Accurate organism identification and susceptibility testing dictate the spectrum of definitive antibiotic therapy.
2
Evaluate the patient's penicillin allergy history.
The patient experienced a maculopapular rash to amoxicillin, which is a non-severe, non-IgE-mediated reaction.
The severity of the prior allergic reaction determines whether structurally related beta-lactam antibiotics can be safely administered.
3
Select the optimal definitive antibiotic therapy for MSSA infective endocarditis based on the patient's history.
Intravenous cefazolin is selected as the definitive treatment.
Beta-lactams are clinically superior to vancomycin for clearing MSSA. Cefazolin has negligible cross-reactivity and is the drug of choice for patients with non-anaphylactic penicillin allergies.

Key Concept

Definitive pharmacotherapy for methicillin-susceptible Staphylococcus aureus (MSSA) infective endocarditis.
Estimated Time:1m 30s
Question 320Question →

A patient with a fifty-pack-year smoking history and severe chronic obstructive pulmonary disease comes to the clinic for a routine follow-up. He is seventy-two years old and reports progressively worsening fatigue, bilateral leg swelling, and right upper quadrant abdominal discomfort over the past few months. His current medications include a long-acting muscarinic antagonist and an inhaled corticosteroid. Vital signs show a respiratory rate of 2222/min and an oxygen saturation of 87%87\% on room air. Physical examination reveals elevated jugular venous pressure, a right ventricular heave, and 2+2+ pitting edema of the lower extremities up to the knees. Auscultation of the heart reveals a loud P2P_2. Lung auscultation shows decreased breath sounds globally without wheezes. Which of the following interventions is most likely to improve long-term survival in this patient?

Show answer & explanation

Answer: Long-term supplemental oxygen therapy

Answer

Long-term supplemental oxygen therapy
The correct answer provides long-term supplemental oxygen therapy. This patient presents with classic signs of cor pulmonale (right ventricular failure due to pulmonary hypertension from severe COPD). His resting oxygen saturation is markedly low at 87%87\%. In such patients with severe resting hypoxemia (defined as SaO2≤88%SaO_2 \le 88\% or PaO2≤55PaO_2 \le 55 mm Hg), long-term supplemental oxygen therapy (usually ≥15\ge 15 hours per day) is the most important intervention because it is one of the only therapies proven to significantly improve long-term survival. It achieves this by relieving hypoxic pulmonary vasoconstriction, which subsequently lowers pulmonary arterial pressure and decreases right ventricular afterload.

Step-by-Step Solution

1
Identify the primary clinical syndrome based on the patient's presentation.
The patient has signs of right-sided heart failure (elevated JVP, right ventricular heave, loud P2, hepatomegaly, and peripheral edema) in the setting of severe COPD and chronic hypoxemia, establishing a diagnosis of cor pulmonale.
Recognizing cor pulmonale isolates the cardiovascular consequence of the patient's underlying chronic lung disease.
2
Determine the specific clinical goal requested by the question stem.
The question specifically asks for the intervention that is most likely to improve 'long-term survival'.
Distinguishing between symptomatic relief and mortality-reducing interventions is critical in chronic cardiopulmonary disease management.
3
Select the evidence-based therapy that meets the survival goal for this condition.
Long-term supplemental oxygen therapy is chosen.
In patients with COPD who have severe resting hypoxemia (oxygen saturation ≤88%\le 88\% or arterial PO2≤55PO_2 \le 55 mm Hg), long-term oxygen therapy has been unequivocally shown to prolong survival by reducing hypoxic pulmonary vasoconstriction and right heart strain.

Key Concept

In patients with cor pulmonale secondary to COPD and severe resting hypoxemia, long-term supplemental oxygen therapy is the primary intervention proven to improve long-term survival.
PreviousPage 16 / 158Next
Internal Medicine Practice Questions — USMLE Step 2 CK — Page 16 | Examkin